Summary & Overview
CPT 89300: Semen Analysis After Intercourse (Postcoital Test, Huhner Test)
CPT code 89300 represents the laboratory-based postcoital test, also known as the Huhner test, which is used to evaluate sperm presence and motility following intercourse. This procedure is a critical tool in reproductive medicine, particularly for the assessment of male infertility. The test is typically performed in a laboratory environment, with CLIA-waived options available for home or point-of-care settings. Nationally, this code is recognized by major commercial payers including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare, reflecting its widespread clinical relevance and coverage.
Readers will gain insight into the clinical context of CPT code 89300, including its role in fertility testing and the types of providers and laboratory settings involved. The publication also covers payer coverage trends, policy updates, and related coding benchmarks, helping stakeholders understand how this code fits into broader reproductive health services. Associated diagnoses such as male infertility and azoospermia, as well as related CPT codes for semen analysis, are discussed to provide a comprehensive overview. This summary is designed for healthcare professionals, billing specialists, and policy analysts seeking up-to-date information on coding, coverage, and clinical applications for semen analysis procedures.
CPT Code Overview
CPT code 89300 is used to report a laboratory procedure known as the postcoital test, or Huhner test, which analyzes semen after intercourse to assess the presence and motility of sperm. This service is a key component of reproductive medicine procedures, particularly in the evaluation of male infertility. The test is typically performed in a laboratory setting, though CLIA-waived versions may be conducted at home or at the point of care. The results provide valuable information for clinicians managing fertility concerns and planning further diagnostic or therapeutic interventions.
Clinical & Coding Specifications
Clinical Context
A patient couple presents to a reproductive medicine clinic with concerns about infertility. The female partner has regular cycles, and the couple has been attempting conception for over a year without success. As part of the infertility evaluation, the clinician orders a postcoital test (Huhner test) to assess sperm presence and motility in cervical mucus after intercourse. The test is performed in a laboratory setting, where a laboratory analyst examines a sample of cervical mucus collected shortly after intercourse to determine if sperm are present and motile. This procedure assists in identifying potential male factor infertility or issues with sperm-mucus interaction.
Coding Specifications
- Modifier
QW: Indicates that the test is CLIA-waived and may be performed at home or at the point of care. Use modifierQWwhen the laboratory performing the test is certified for CLIA-waived testing.
| Modifier Code | Description |
|---|---|
| QW | CLIA waived test |
- Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
| 207V00000X | Obstetrics & Gynecology Physician |
| 207U00000X | Clinical Laboratory Director, Non-physician |
| 207Q00000X | Family Medicine Physician |
Related Diagnoses
-
N46.9- Male infertility, unspecified- Relevant for patients undergoing fertility evaluation where the cause of infertility is not yet determined.
-
Z31.41- Encounter for fertility testing- Used when the visit is specifically for fertility testing, including procedures like the postcoital test.
-
N46.01- Azoospermia- Indicates absence of sperm in semen, which may be identified through semen analysis or postcoital testing.
-
N46.11- Oligospermia- Refers to low sperm count, a finding that can be assessed with semen analysis and postcoital tests.
-
N46.8- Other male infertility- Used for other specified types of male infertility that may be evaluated with the postcoital test.
Related CPT Codes
-
89310- Semen analysis including motility and count, without Huhner test- Used for semen analysis that does not involve the postcoital (Huhner) test. May be performed as an alternative or in addition to
89300.
- Used for semen analysis that does not involve the postcoital (Huhner) test. May be performed as an alternative or in addition to
-
89320- Semen analysis volume, count, motility- Focuses on measuring semen volume, sperm count, and motility. Often used in male infertility workups alongside or instead of
89300.
- Focuses on measuring semen volume, sperm count, and motility. Often used in male infertility workups alongside or instead of
-
89321- Semen analysis sperm detection- Used to detect the presence of sperm in a sample. Can be used in conjunction with
89300for confirmation.
- Used to detect the presence of sperm in a sample. Can be used in conjunction with
-
89322- Semen analysis strict criteria- Applies strict morphological criteria to sperm analysis. May be used as a follow-up or complementary test to
89300when detailed sperm morphology is needed.
- Applies strict morphological criteria to sperm analysis. May be used as a follow-up or complementary test to
These codes are commonly used together or as alternatives in the clinical workflow for evaluating male infertility and sperm function.
National Reimbursement Benchmarks
National mean rates for CPT code 89300 show that BUCA (average commercial) payers reimburse at $9.82, while Medicare rates are not available in the input. Among individual commercial payers, Cigna has the highest mean rate at $12.43, and Aetna the lowest at $7.71.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, is widest for Cigna ($7.00) and tightest for Aetna ($3.25). This indicates that Cigna's rates vary more across providers, while Aetna's rates are more consistent nationally. Blue Cross Blue Shield, UnitedHealth Group, and BUCA all show moderate dispersion, ranging from $4.00 to $4.08.
The table and chart below present the full breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.